Oragenics Inc
OGEN- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001174940
No open-market purchases or sales by Oragenics Inc insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $39.2K in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Oragenics Inc changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 20 | 17 | −3 |
| Shares | 189.4K | 67.5K | −121.9K (−64.3%) |
| Value | $105.8K | $39.2K | −$66.6K (−62.9%) |
New holders (2)
Institutions that held Oragenics Inc at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| 25 LLC | 23,160 | $13.4K | 0.00% |
| Jane Street Group, LLC | 12,771 | $7.41K | 0.00% |
Sold out (5)
Institutions that held Oragenics Inc at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Pathstone Holdings, LLC | 55,001 | $30.8K |
| Two Sigma Securities, LLC | 20,343 | $11.4K |
| HRT Financial LP | 18,672 | $10.0K |
| Virtu Financial LLC | 17,575 | $10.0K |
| Ameritas Advisory Services, LLC | 2,000 | $1.12K |